Prolocor Inc | WebDisclosure

Basculer en Français

11277	Companies
250588	Keywords
179221	Articles
136422	Press releases

Home
Companies
Prolocor Inc

BRIEF

published on 02/20/2024 at 15:00, 2 years 8 months ago

Prolocor, Inc. Introduces a Breakthrough in Thrombosis Risk Diagnosis

Prolocor Thrombosis Precision Diagnosis Cardiology Medical Innovation
PRESS RELEASE

published on 02/20/2024 at 15:00, 2 years 8 months ago

Prolocor to Present New Clinical Evidence at ACC 24 Supporting the Use of PLATELET FCɣRIIA (PFCG) as a Key Tool in Individualizing Dual Antiplatelet Therapy (DAPT)
Prolocor, Inc. announces acceptance of abstract on platelet FcγRIIa implications in myocardial infarction treatment strategy at ACC Scientific Sessions 2024

Prolocor Inc. Platelet FcγRIIa Myocardial Infarction Treatment Strategy Clinical Program

Accesswire

Published on 11/04/2026 at 23:10, 4 hours 43 minutes ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 4 hours 53 minutes ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 4 hours 53 minutes ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 38 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 5 hours 48 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 03:10, 42 minutes ago

SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 3 hours 50 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 8 hours 11 minutes ago

EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 8 hours 27 minutes ago

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 9 hours 9 minutes ago

EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year

Les Echos

Published on 11/04/2026 at 18:00, 9 hours 52 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 9 hours 52 minutes ago

L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:45, 10 hours 8 minutes ago

October 2026
Published on 11/04/2026 at 17:45, 10 hours 8 minutes ago

Octobre 2026
Published on 11/04/2026 at 17:44, 10 hours 9 minutes ago

Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE